[ad_1] Cidara Therapeutics Inc CDTX has submitted a marketing application to the FDA seeking approval for rezafungin for candidemia and invasive candidiasis. The company has also entered into a license agreement…
[ad_1] CinPax LLC has acquired around 4.1 million shares of vTv Therapeutics Inc VTVT at approximately $2.41 per share, with $6 million paid in cash at closing and the remaining $4 million payable on…
[ad_1] ResMed Inc RMD has redesigned the AirSense 10 to eliminate a short-supply semiconductor chipset used for cellular communications chips. Instead of offering wireless communications capability, the new AirSense…
[ad_1] Here’s a roundup of top developments in the biotech space over the last 24 hours: VistaGen Therapeutics Inc VTGN has announced topline results from its PALISADE-1 Phase 3 trial of PH94B for…
[ad_1] by Vandana Singh, Benzinga Editor July 22, 2022 6:06 AM | 1 min read Same-hospital net patient service revenue per adjusted admission decreased 0.2% due to the cybersecurity incident.…